Skip to NavigationSkip to content

News

Bristol-Myers Squibb’s Sprycel (dasatinib) has secured an expanded indication in Europe, the company said, with the European Commission...
Melbourne-based medicinal cannabis company Althea has become one of the first companies to enter the UK market after the British government made...
Janssen has announced that its esketamine nasal spray Spravato has been recommended by the FDA’s advisory panel for the treatment of treatment-...
Researchers at the Medical University of South Carolina (MUSC) have discovered a new type of cell membrane complex which causes cells to explode....
British company Clinigen has bought the rights to sell Novartis’ cancer drug Proleukin in the United States in a deal worth $210 million.
It’s bad news for Scottish patients living with aggressive forms of non-Hodgkin lymphoma (NHL) as it emerges that the Scottish Medicines Consortium...
Peter Edward Dawson-Ball, the financial head of the Guernsey-based firm Immuno Biotech, that sold unlicensed blood product GcMAF, has been found...
New data has been revealed on the efficacy of MSD’s Keytruda in combination with Pfizer’s Inlyta, showing it successfully reduced the risk of death...
The FDA is cracking down on those selling ‘dietary supplements’, having sent warning letters to companies who claim, without proof, that their...
Gilead’s treatment for the progressive fatty liver disease, NASH, has failed to meet its primary goal in a phase 3 trial, causing shares in the...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches